Interim Results from the CATNON trial (EORTC study 260-53-22054) of treatment with Concurrent and Adjuvant Temozolomide for 1p/19q non-co-deleted anaplastic glioma: A phase 3, randomized, open-label intergroup study
Lancet 390:1645-1653, Van Den Bent, M.J.,et al, 2017
Metastatic spinal cord compression
BMJ 342:d2402, Quraishi, N. & Esler, C., 2011
Diagnosis and Management of Patients at Risk of or with Metastatic Spinal Cord Compression: Summary of NICE Guidance
BMJ 337:1349-1351, White,B.D.,et al, 2008
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
NEJM 356:664-672, Slotman,B.,et al, 2007
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
Practice Parameter: Anticonvulsant Prophylaxis in Patients With Newly Diagnosed Brain Tumors
Neurol 54:1886-1893, Glantz,M.J.,et al, 2000
Disparities and Guideline Adherence in Drugs of Abuse Screening in Intracerebral Hemorrhage
Neurol 88:252-258, Tomoehlen, L.M.,et al, 2017
Anal Carcinoma
NCCN.org April 2017 V2.2017, , 2017
International Consensus Guidance for Management of Myasthenia Gravis
Neurol 87:419-425, Sanders, D.B.,et al, 2016
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Statins and Intracerebral Hemorrhage
Arch Neurol 69:39-45,13, Hackam,D.G,et al, 2012
Evidence-based Guideline: Antiepileptic Drug Selection for People with HIV/AIDS
Neurol 78:139-145, Birbeck,G.L.,et al, 2012
Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011
Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010
Variability of Brain Death Determination Guidelines in Leading US Neurologic Institutions
Neurol 70:284-289,252, Greer,D.M.,et al, 2008
The Tuberous Sclerosis Complex
NEJM 355:1345-1356, Crino,P.B.,et al, 2006
Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes
JNNP 75:1135-1140,1090, Graus,F.,et al, 2004
Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 61:736-740, Hughes,R.A.C.,et al, 2003
Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002
Brain Biopsy in Patients with Acquired Immunodeficiency Syndrome, Diagnostic Value, Clinical Performance, and Survival Time
Arch Int Med 159:2590-2596, Hornef,M.W.,et al, 1999
Evaluation and Management of Intracranial Mass Lesions in AIDS
Rpt of Quality Stnds Subcomm of the AAN, Neurol 50:21-261998., , 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Optic Pathway Gliomas in Children with Neurofibromatosis 1:Consensus Stmt NF1 Optic Pathway Glioma Task Force
Ann Neurol 41:143-149, Listernick,R.,et al, 1997
Determining Brain Death in Adults
Neurol 45:1003-1011, Wijdicks,E.F.M., 1995
Variability in Brain Death Determination Practices in Children
JAMA 274:550-553, Mejia,R.E.&Pollack,M.M., 1995
Guidelines on the Detection of Paraneoplastic Anti-Neuronal-Specific Antibodies
Neurol 45:1937-1941, Moll,J.W.B.,et al, 1995
Practice Parameter for Diagnosis and Evaluation of Dementia (Summary Statement) Alter
M. , et al, Neurol 44:2203-220694., , 1994